Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma.

Schieffer KM, Varga E, Miller KE, Agarwal V, Koboldt DC, Brennan P, Kelly B, Dave-Wala A, Pierson CR, Finlay JL, AbdelBaki MS, White P, Magrini V, Wilson RK, Mardis ER, Cottrell CE.

Eur J Med Genet. 2019 Jun 10:103701. doi: 10.1016/j.ejmg.2019.103701. [Epub ahead of print]

PMID:
31195167
2.

Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.

Gittleman H, Cioffi G, Vecchione-Koval T, Ostrom QT, Kruchko C, Osorio DS, Finlay JL, Barnholtz-Sloan JS.

J Neurooncol. 2019 Jun;143(2):251-260. doi: 10.1007/s11060-019-03173-4. Epub 2019 Apr 25.

PMID:
31025275
3.

Critical review of the management of primary central nervous nongerminomatous germ cell tumors.

Abu Arja MH, Bouffet E, Finlay JL, AbdelBaki MS.

Pediatr Blood Cancer. 2019 Jun;66(6):e27658. doi: 10.1002/pbc.27658. Epub 2019 Feb 15. Review.

PMID:
30767415
4.

Germinoma Involving the Retina: An Unusual Presentation of Recurrent Intracranial Mixed Germ Cell Tumor.

Abu Arja MH, Stalling M, Governale LS, Pierson CR, Rusin JA, Palmer JD, Finlay JL, Olshefski R, Boué DR.

World Neurosurg. 2019 Jan 7. pii: S1878-8750(19)30002-6. doi: 10.1016/j.wneu.2018.12.143. [Epub ahead of print]

PMID:
30630044
5.

Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma.

Shackleford GM, Mahdi MY, Moats RA, Hawes D, Tran HC, Finlay JL, Hoang TQ, Meng EF, Erdreich-Epstein A.

PLoS One. 2019 Jan 4;14(1):e0206394. doi: 10.1371/journal.pone.0206394. eCollection 2019.

6.

The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource.

Abu Arja MH, Stanek JR, Morales La Madrid AE, Lassaletta A, Bartels U, Qaddoumi I, Finlay JL, Osorio DS.

Childs Nerv Syst. 2019 Feb;35(2):257-265. doi: 10.1007/s00381-018-4000-x. Epub 2018 Nov 14.

PMID:
30426208
7.

Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.

Osorio DS, Patel N, Ji L, Sposto R, Stanek J, Gardner SL, Allen JC, Cornelius A, McCowage GB, Termuhlen A, Dunkel IJ, Comito M, Garvin J, Finlay JL.

J Neurooncol. 2018 Dec;140(3):717-725. doi: 10.1007/s11060-018-03003-z. Epub 2018 Nov 3.

PMID:
30392092
8.

Targeting Upstream Kinases of STAT3 in Human Medulloblastoma cells.

Wei J, Ma L, Li C, Pierson CR, Finlay JL, Lin J.

Curr Cancer Drug Targets. 2018 Oct 16. doi: 10.2174/1568009618666181016165604. [Epub ahead of print]

PMID:
30332965
9.

Complete Remission of an Extracranially Disseminated Anaplastic Pleomorphic Xanthoastrocytoma With Everolimus: A Case Report and Literature Review.

Saraf AJ, Elhawary G, Finlay JL, Scott S, Olshefski R, Halverson M, Boue DR, AbdelBaki MS.

Pediatr Neurol. 2018 Nov;88:65-70. doi: 10.1016/j.pediatrneurol.2018.09.004. Epub 2018 Sep 13. Review.

PMID:
30322731
10.

Re-induction chemotherapy regimens in patients with recurrent central nervous system mixed malignant germ cell tumors.

Abu Arja MH, Stanek JR, Finlay JL, AbdelBaki MS.

Childs Nerv Syst. 2018 Nov;34(11):2179-2186. doi: 10.1007/s00381-018-3940-5. Epub 2018 Aug 3. Review.

PMID:
30076436
11.

Pediatric choroid plexus carcinoma: Biologically and clinically in need of new perspectives.

Zaky W, Finlay JL.

Pediatr Blood Cancer. 2018 Jul;65(7):e27031. doi: 10.1002/pbc.27031. Epub 2018 Mar 12. Review.

PMID:
29528196
12.

Genome sequencing identifies somatic BRAF duplication c.1794_1796dupTAC;p.Thr599dup in pediatric patient with low-grade ganglioglioma.

Miller KE, Kelly B, Fitch J, Ross N, Avenarius MR, Varga E, Koboldt DC, Boué DR, Magrini V, Coven SL, Finlay JL, Cottrell CE, White P, Gastier-Foster JM, Wilson RK, Leonard J, Mardis ER.

Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). pii: a002618. doi: 10.1101/mcs.a002618. Print 2018 Apr.

13.

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Robison NJ, Yeo KK, Berliner AP, Malvar J, Sheard MA, Margol AS, Seeger RC, Rushing T, Finlay JL, Sposto R, Dhall G.

J Neurooncol. 2018 May;138(1):199-207. doi: 10.1007/s11060-018-2791-y. Epub 2018 Feb 9.

14.

Pediatric low-grade gliomas: a brave new world.

Rubin JB, Finlay JL.

Neuro Oncol. 2018 Jan 22;20(2):149-150. doi: 10.1093/neuonc/nox221. No abstract available.

15.

Brentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome.

Abu Arja MH, Conley SE, Salceda V, Al-Sufiani F, Boué DR, Finlay JL.

Childs Nerv Syst. 2018 Apr;34(4):777-780. doi: 10.1007/s00381-017-3690-9. Epub 2017 Dec 13.

PMID:
29236132
16.

Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.

Chen X, Wei J, Li C, Pierson CR, Finlay JL, Lin J.

Int J Oncol. 2018 Feb;52(2):571-578. doi: 10.3892/ijo.2017.4211. Epub 2017 Nov 22.

17.

Desmoplastic nodular medulloblastoma in young children: a management dilemma.

AbdelBaki MS, Boué DR, Finlay JL, Kieran MW.

Neuro Oncol. 2018 Jul 5;20(8):1026-1033. doi: 10.1093/neuonc/nox222.

PMID:
29156007
18.

Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.

Haworth KB, Arnold MA, Pierson CR, Choi K, Yeager ND, Ratner N, Roberts RD, Finlay JL, Cripe TP.

Oncotarget. 2017 May 30;8(47):82037-82048. doi: 10.18632/oncotarget.18301. eCollection 2017 Oct 10.

19.

T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study.

Morana G, Alves CA, Tortora D, Finlay JL, Severino M, Nozza P, Ravegnani M, Pavanello M, Milanaccio C, Maghnie M, Rossi A, Garrè ML.

Neuroradiology. 2018 Jan;60(1):89-99. doi: 10.1007/s00234-017-1947-3. Epub 2017 Nov 11.

PMID:
29128947
20.

Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.

Salloum R, McConechy MK, Mikael LG, Fuller C, Drissi R, DeWire M, Nikbakht H, De Jay N, Yang X, Boue D, Chow LML, Finlay JL, Gayden T, Karamchandani J, Hummel TR, Olshefski R, Osorio DS, Stevenson C, Kleinman CL, Majewski J, Fouladi M, Jabado N.

Acta Neuropathol Commun. 2017 Oct 30;5(1):78. doi: 10.1186/s40478-017-0479-8.

21.

Tandem thiotepa with autologous hematopoietic cell rescue in patients with recurrent, refractory, or poor prognosis solid tumor malignancies.

Osorio DS, Dunkel IJ, Cervone KA, Goyal RK, Steve Lo KM, Finlay JL, Gardner SL.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26776. Epub 2017 Sep 14.

PMID:
28905508
22.

Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.

Guerra JA, Dhall G, Marachelian A, Castillo E, Malvar J, Wong K, Sposto R, Finlay JL.

Bone Marrow Transplant. 2017 Nov;52(11):1543-1548. doi: 10.1038/bmt.2017.166. Epub 2017 Aug 7.

PMID:
28783147
23.

Long-term follow-up of endocrine function among young children with newly diagnosed malignant central nervous system tumors treated with irradiation-avoiding regimens.

Cochrane AM, Cheung C, Rangan K, Freyer D, Nahata L, Dhall G, Finlay JL.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26616. Epub 2017 May 5.

PMID:
28475292
24.

Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III.

Wong KK, All S, Waxer J, Olch AJ, Venkatramani R, Dhall G, Davidson TB, Zaky W, Finlay JL.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26529. Epub 2017 Apr 5.

PMID:
28379644
25.

Cerebellopontine angle tumors in young children, displaying cranial nerve deficits, and restricted diffusion on diffusion-weighted imaging: a new clinical triad for atypical teratoid/rhabdoid tumors.

Katz JS, Peruzzi PP, Pierson CR, Finlay JL, Leonard JR.

Childs Nerv Syst. 2017 May;33(5):833-838. doi: 10.1007/s00381-017-3384-3. Epub 2017 Mar 22.

PMID:
28332155
26.

The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.

Tian J, Xiao H, Wu R, Cao Y, Li C, Xu R, Pierson CR, Finlay JL, Yang F, Gu N, Lin J.

Anticancer Res. 2017 Feb;37(2):547-553.

27.

Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.

Mynarek M, Pizer B, Dufour C, van Vuurden D, Garami M, Massimino M, Fangusaro J, Davidson T, Gil-da-Costa MJ, Sterba J, Benesch M, Gerber N, Juhnke BO, Kwiecien R, Pietsch T, Kool M, Clifford S, Ellison DW, Giangaspero F, Wesseling P, Gilles F, Gottardo N, Finlay JL, Rutkowski S, von Hoff K.

Neuro Oncol. 2017 Apr 1;19(4):576-585. doi: 10.1093/neuonc/now234.

28.

False-positive magnetic resonance imaging findings in follow-up of pediatric patients with tumors of the central nervous system.

De Oliveira SN, Gonzalez-Gomez I, Panigrahy A, Krieger M, McComb G, Finlay JL, Dhall G.

SAGE Open Med Case Rep. 2016 Aug 26;4:2050313X16666232. doi: 10.1177/2050313X16666232. eCollection 2016.

29.

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.

Samuel N, Wilson G, Lemire M, Id Said B, Lou Y, Li W, Merino D, Novokmet A, Tran J, Nichols KE, Finlay JL, Choufani S, Remke M, Ramaswamy V, Cavalli FMG, Elser C, Meister L, Taylor MD, Tabori U, Irwin M, Weksberg R, Wasserman JD, Paterson AD, Hansford JR, Achatz MIW, Hudson TJ, Malkin D.

J Clin Oncol. 2016 Oct 20;34(30):3697-3704. doi: 10.1200/JCO.2016.67.6940.

30.

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.

Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin D.

Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5.

PMID:
27501770
31.

SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.

Mangum R, Varga E, Boué DR, Capper D, Benesch M, Leonard J, Osorio DS, Pierson CR, Zumberge N, Sahm F, Schrimpf D, Pfister SM, Finlay JL.

Childs Nerv Syst. 2016 Dec;32(12):2439-2446. Epub 2016 Jul 21. Review.

PMID:
27444290
32.

Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.

Espinoza JC, Haley K, Patel N, Dhall G, Gardner S, Allen J, Torkildson J, Cornelius A, Rassekh R, Bedros A, Etzl M, Garvin J, Pradhan K, Corbett R, Sullivan M, McGowage G, Stein D, Jasty R, Sands SA, Ji L, Sposto R, Finlay JL.

Pediatr Blood Cancer. 2016 Oct;63(10):1806-13. doi: 10.1002/pbc.26118. Epub 2016 Jun 22.

33.

Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature.

Wong K, Opimo AB, Olch AJ, All S, Waxer JF, Clark D, Cheng J, Chlebik A, Erdreich-Epstein A, Krieger MD, Tamrazi B, Dhall G, Finlay JL, Chang EL.

Cureus. 2016 Apr 25;8(4):e585. doi: 10.7759/cureus.585. Review.

34.

High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).

Nazemi KJ, Shen V, Finlay JL, Boyett J, Kocak M, Lafond D, Gardner SL, Packer RJ, Nicholson HS.

Pediatr Blood Cancer. 2016 Sep;63(9):1563-70. doi: 10.1002/pbc.26074. Epub 2016 May 20.

35.

A Ruby Anniversary.

Finlay JL.

J Clin Oncol. 2016 Jul 1;34(19):2312-3. doi: 10.1200/JCO.2016.67.1545. Epub 2016 May 9. No abstract available.

PMID:
27161960
36.

Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009.

Altshuler C, Haley K, Dhall G, Vasquez L, Gardner SL, Stanek J, Finlay JL.

Bone Marrow Transplant. 2016 Jul;51(7):945-8. doi: 10.1038/bmt.2016.45. Epub 2016 Mar 7.

PMID:
26950375
37.

Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.

Egan G, Cervone KA, Philips PC, Belasco JB, Finlay JL, Gardner SL.

Bone Marrow Transplant. 2016 Apr;51(4):542-5. doi: 10.1038/bmt.2015.313. Epub 2016 Jan 4.

PMID:
26726947
38.

American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R, Stearns DS, Wolff JE, Liu M, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2016 Jan;18 Suppl 1:i1-i50. doi: 10.1093/neuonc/nov297. No abstract available.

39.

The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experience.

Bouffet E, Allen JC, Boyett JM, Yates A, Gilles F, Burger PC, Davis RL, Becker LE, Pollack IF, Finlay JL.

J Neurosurg Pediatr. 2016 Apr;17(4):453-9. doi: 10.3171/2015.10.PEDS1581. Epub 2015 Dec 18.

40.

Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia.

Xu J, Margol AS, Shukla A, Ren X, Finlay JL, Krieger MD, Gilles FH, Couch FJ, Aziz M, Fung ET, Asgharzadeh S, Barrett MT, Erdreich-Epstein A.

Front Oncol. 2015 Aug 27;5:191. doi: 10.3389/fonc.2015.00191. eCollection 2015.

41.

Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.

Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, Asgharzadeh S.

Neuro Oncol. 2016 Jan;18(1):126-31. doi: 10.1093/neuonc/nov097. Epub 2015 Aug 8.

42.

Diffusion Tensor Imaging and Neurobehavioral Outcome in Children With Brain Tumors Treated With Chemotherapy.

Baron Nelson M, Compton P, Macey PM, Patel SK, Jacob E, O'Neil S, Ogren J, Finlay JL, Harper RM.

J Pediatr Oncol Nurs. 2016 Mar-Apr;33(2):119-28. doi: 10.1177/1043454215590104. Epub 2015 Jul 27.

43.

Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.

Cohen BH, Geyer JR, Miller DC, Curran JG, Zhou T, Holmes E, Ingles SA, Dunkel IJ, Hilden J, Packer RJ, Pollack IF, Gajjar A, Finlay JL; Children's Oncology Group.

Pediatr Neurol. 2015 Jul;53(1):31-46. doi: 10.1016/j.pediatrneurol.2015.03.019. Epub 2015 Apr 9.

44.

Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.

Pruitt R, DaSilva NS, Cappellano A, Belessiotis C, Diez B, Gardner S, Allen J, Weinblatt M, Gottardo N, Dhall G, Finlay JL.

Pediatr Blood Cancer. 2015 Nov;62(11):1920-4. doi: 10.1002/pbc.25606. Epub 2015 Jun 5.

PMID:
26054044
45.

Graft versus tumor effect in the brain of a child with recurrent metastatic medulloblastoma.

Abdel-Azim H, Kapoor N, Mahadeo KM, Finlay JL.

Pediatr Blood Cancer. 2015 Sep;62(9):1667-9. doi: 10.1002/pbc.25525. Epub 2015 Apr 20.

PMID:
25894457
46.

Choroid plexus carcinoma in children: the Head Start experience.

Zaky W, Dhall G, Khatua S, Brown RJ, Ginn KF, Gardner SL, Yildiz VO, Yankelevich M, Finlay JL.

Pediatr Blood Cancer. 2015 May;62(5):784-9. doi: 10.1002/pbc.25436. Epub 2015 Feb 8.

PMID:
25662896
47.

The management of children and adolescents with medulloblastoma in low and middle income countries.

Gajjar A, Finlay JL.

Pediatr Blood Cancer. 2015 Apr;62(4):549-50. doi: 10.1002/pbc.25371. Epub 2014 Dec 24. No abstract available.

PMID:
25545387
48.

Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS.

Neuro Oncol. 2015 Jan;16 Suppl 10:x1-x36. doi: 10.1093/neuonc/nou327.

49.

Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.

Eisenstat DD, Pollack IF, Demers A, Sapp MV, Lambert P, Weisfeld-Adams JD, Burger PC, Gilles F, Davis RL, Packer R, Boyett JM, Finlay JL.

J Neurooncol. 2015 Feb;121(3):573-81. doi: 10.1007/s11060-014-1669-x. Epub 2014 Nov 28.

50.

Tumor-associated macrophages in SHH subgroup of medulloblastomas.

Margol AS, Robison NJ, Gnanachandran J, Hung LT, Kennedy RJ, Vali M, Dhall G, Finlay JL, Erdreich-Epstein A, Krieger MD, Drissi R, Fouladi M, Gilles FH, Judkins AR, Sposto R, Asgharzadeh S.

Clin Cancer Res. 2015 Mar 15;21(6):1457-65. doi: 10.1158/1078-0432.CCR-14-1144. Epub 2014 Oct 24.

Supplemental Content

Loading ...
Support Center